Product Information
QUETIAPINE ER 400 MG TABLET is a generic product labeled by ACI Healthcare USA, Inc., priced at $0.3226 per EA under NDC 71093013902. Its NADAC has been published 419 times since May 16, 2018.
FDA first approved this application on Nov 29, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
ACI Healthcare USA, Inc.NDC
71093013902
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA209635FDA Approved
11/29/2017
TE Code
AB
On Market Since
11/29/2017
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE ER 400 MG TABLET has been published 419 times since May 16, 2018, and over the history we have for it it has declined 64.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3226 per EA |
|---|---|
| All-time high | $0.9277 (Jun 13, 2018) |
| All-time low | $0.2506 (Jul 17, 2024) |
| 52-week high | $0.3390 |
| 52-week low | $0.3021 |
| Median price | $0.4326 |
| Average price | $0.4787 |
| Largest weekly change | +47.1% (Aug 21, 2024) |
| Weeks tracked | 419 |
| Tracking since | May 16, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
-4.8%
1Y
+5.6%
3Y
-32.2%
5Y
-39.2%
All
-64.0%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUETIAPINE ER 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 400 MG TABLET, manufactured by ACI Healthcare USA, Inc., is $0.3226 per EA (NDC 71093013902), effective May 20, 2026.
How has the price of QUETIAPINE ER 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUETIAPINE ER 400 MG TABLET has declined 64.0%. It has been tracked across 419 weekly CMS publications since May 16, 2018.
What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 400 MG TABLET?
Since May 16, 2018, the NADAC for QUETIAPINE ER 400 MG TABLET has ranged from a low of $0.2506 (Jul 17, 2024) to a high of $0.9277 (Jun 13, 2018), with a median of $0.4326 per EA.
Are there cheaper alternatives to QUETIAPINE ER 400 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 400 MG TAB, is $0.1548 per EA — about 52% below QUETIAPINE ER 400 MG TABLET.
Who manufactures QUETIAPINE ER 400 MG TABLET?
QUETIAPINE ER 400 MG TABLET (NDC 71093013902) is labeled by ACI Healthcare USA, Inc., and CMS classifies it as a generic product.